443-48-1
443-48-1
Chemical Structure
Metronidazole
- CAS No.: 443-48-1
- Formula:C6H9N3O3
- Molecular Weight:171.16
IUPAC Name: 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethan-1-ol
InChIKey: VAOCPAMSLUNLGC-UHFFFAOYSA-N
SMILES: OCCN1C([N+]([O-])=O)=CN=C1C
Biological Activity: Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Metronidazole | 99.98% | Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Metronidazole (Standard) | 99.99% | Metronidazole (Standard) is the analytical standard of Metronidazole. This product is intended for research and analytical applications. Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Metronidazole-13C2,15N2 | 99.30% | Metronidazole-13C2,15N2 is the 13C-labeled and 15N-labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Metronidazole-d3 | 99.9% | Metronidazole-d3 is deuterium labeled Metronidazole. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Metronidazole-d4 | 98.25% | Metronidazole-d4 is the deuterium labeled Metronidazole. Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Scully BE. Metronidazole. Med Clin North Am. 1988 May;72(3):613-21. [Content Brief]
- [2]. Dhurga DB, et al. Granular Formation during Apoptosis in Blastocystis sp. Exposed to Metronidazole (MTZ). PLoS One. 2016 Jul 29;11(7):e0155390. [Content Brief]
- [3]. Chaturvedi S, et al. Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines. Neurotoxicology. 2020 Jul;79:1-10. [Content Brief]
- [4]. Manickam R, et al. Metronidazole Causes Skeletal Muscle Atrophy and Modulates Muscle Chronometabolism. Int J Mol Sci. 2018 Aug 16;19(8):2418. [Content Brief]
